Glutathione Reductase and Dementia Reductions in glutathione reductase (GR) enzyme levels in patients with dementia are well established
Patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 may not be appropriate candidates for certain GLP-1 medications
However, as a precaution, semaglutide should not be prescribed to individuals with a personal or family history of medullary thyroid carcinoma (MTC) or those with multiple endocrine neoplasia syndrome type 2 (MEN2)
37.7%, HR = 0.23, 95% CI 0.210.26) [58]
Pharmacists Perspective Faryal Faisal, PharmD SURMOUNT-5 is significant because it was a direct, randomised comparison not two separate trials being indirectly compared
Overall, my experience with MDWatch has been outstanding